药物信息为CASODEX (bicalutamide) TABLETS (AstraZeneca Pharnaceuticals LP): DOSAGE AND ADMINISTRATION
- DESCRIPTION
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- ADVERSE REACTIONS
- OVERDOSAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- Diseases/Conditions Related to CASODEX (bicalutamide) TABLETS (AstraZeneca Pharnaceuticals LP)
- 外部链接相关的CASODEX (bicalutamide) TABLETS (AstraZeneca Pharnaceuticals LP)
The recommended dose for CASODEX therapy in combination with an LHRH analogue is one 50 mg tablet once daily (morning or evening), with or without food. It is recommended that CASODEX be taken at the same time each day. Treatment with CASODEX should be started at the same time as treatment with an LHRH analogue.
Dosage Adjustment in Renal Impairment:
No dosage adjustment is necessary for patients with renal impairment (see CLINICAL PHARMACOLOGY, Special Populations, Renal Insufficiency).
Dosage Adjustment in Hepatic Impairment:
No dosage adjustment is necessary for patients with mild to moderate hepatic impairment. Although there is a 76% (5.9 and 10.4 days for normal and impaired patients, respectively) increase in the half-life of the active enantiomer of bicalutamide in patients with severe liver impairment (n=4), no dosage adjustment is necessary (see CLINICAL PHARMACOLOGY, Special Populations, Hepatic Impairment, PRECAUTIONSand WARNINGSsections).
- Drug Information Provided by National Library of Medicine (NLM).
